30
Apr
Europe: DSM buys HMO company for US$836M
Royal DSM has completed its acquisition of Glycom, a global supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of €765 million (US$836.4 million). The acquisition of Glycom was first announced on 21 February 2020. This adds to DSM’s…
View
